Janssen RSV Vaccine for Older Adults Drives Robust Cellular Immune, Humoral Response
October 04, 2021

Janssen's investigational vaccine showed efficacy of up to 80% in preventing RSV-mediated lower respiratory tract infections in older adults.

Black Women with HIV at Highest Risk for Premature Mortality a 21-year Study Finds
October 01, 2021

IDWeek 2021: Despite declining mortality rates among patients with HIV in the past 2 decades, a new study finds significant disparities in gender and race.

People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
October 01, 2021

Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.

CDI-specific Follow-up Visits Rare among Patients Hospitalized for Recurrence
September 30, 2021

IDWeek 2021: A new study found that only 16% of patients with CDI rehospitalized for recurrent infection had been seen in follow-up 30 days after original discharge.

Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
September 30, 2021

Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.

Obesity May Put Children Hospitalized with COVID-19 at Higher Risk for Severe Disease, Suggests New Study
September 29, 2021

IDWeek 2021: Obesity prevention and vaccination efforts may help prevent COVID-19-related morbidity in pediatric COVID-19 patients with obesity, noted authors of a new study.

IDWeek 2021: C diff Clinical Outcomes Unchanged after 2017 IDSA Guideline Update
September 29, 2021

IDWeek 2021: Use of vancomycin vs metronidazole increased after the 2017 IDSA recommendation but CDI recurrence rates increased slightly, investigators report.

HCV Cure is Possible in Young Drug Users, Suggests New Research Being Presented at IDWeek 2021
September 28, 2021

IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.

Remdesivir May Significantly Reduce Risk of Hospitalization in High-risk COVID-19 Patients, Suggests New Study
September 23, 2021

Findings from a phase 3 clinical trial showed remdesivir reduced the risk of COVID-19-related hospitalizations by 87% in high-risk patients, the drug's manufacturer announced.

Antibiotic Prescriptions for ARIs More Likely at Day’s End
October 12, 2013

An IDWeek 2013 poster presentation quantified clinician fatigue with the finding that Boston-area primary care physicians were more likely to prescribe antibiotics for ARIs at the end of the day than when they were fresh on the job in the morning.